beta-lactams has been researched along with Chlamydial Pneumonia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, P; Li, X; Tang, Y; Tu, X; Wu, J; Xia, H; Xiao, T; Yan, K | 1 |
| Arnold, C; Bassetti, S; Piso, RJ | 1 |
2 other study(ies) available for beta-lactams and Chlamydial Pneumonia
| Article | Year |
|---|---|
Clinical, radiological and pathological characteristics of moderate to fulminant psittacosis pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Chlamydial Pneumonia; Chlamydophila psittaci; Humans; Hyperplasia; Middle Aged; Pneumonia; Psittacosis; Retrospective Studies | 2022 |
Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; beta-Lactams; Chlamydial Pneumonia; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Guideline Adherence; Hospitalization; Humans; Immunocompromised Host; Legionnaires' Disease; Macrolides; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index | 2013 |